— LISTEE'S SPOTLIGHT —

Marlene Elisabeth Haffner, MD, MPH, founder and principal of Haffner Associates LLC, is highly regarded in the medical industry. She and her team collaborate with biotech and pharmaceutical companies, patients, and patient advocacy groups to provide drug/biological development assistance for the diagnosis, treatment and prevention of rare diseases. Dr. Haffner is also an adjunct professor at the F. Edward Hébert School of Medicine of the Uniformed Services University of the Health Sciences and at the U.S. Public Health Service (USPHS). Prior, she was the director of the Office of Orphan Products Development for the Food and Drug Administration (FDA) from 1986 to 2007, where she was responsible for administrating the United States Orphan Drug Act. In recognition of her work, Orphan Product Development programs have been developed globally. She also served with USPHS between 1971 and 2007, retiring as Rear Admiral. She was honored with the Lifetime Achievement Award from the European Organization for Rare Disorders in 2014. She also twice received the Distinguished Service Medal from USPHS, the highest USPHS award. She holds an MD from The George Washington School of Medicine and an MPH in health policy and management from the Johns Hopkins Bloomberg School of Public Health.